Cargando…

Population‐based cross‐sectional study on insulin resistance and insulin‐secretory capacity in Japanese school children

AIMS/INTRODUCTION: Little information is available regarding the status of insulin resistance (IR) and insulin deficiency (ID), as well as their relationship with obesity in children using the homeostasis model assessment (HOMA) in a population‐based setting. MATERIALS AND METHODS: The study include...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishimura, Rimei, Sano, Hironari, Onda, Yoshiko, Tsujino, Daisuke, Ando, Kiyotaka, Ebara, Futoshi, Matsudaira, Toru, Ishikawa, Shinichiro, Sakamoto, Takuya, Tajima, Naoko, Utsunomiya, Kazunori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583948/ https://www.ncbi.nlm.nih.gov/pubmed/28130842 http://dx.doi.org/10.1111/jdi.12637

Ejemplares similares

Biphasic insulin aspart‐30 reduces glycemic variability to a greater degree than insulin detemir: A randomized controlled trial of once‐daily insulin regimens using continuous glucose monitoring
por: Tsujino, Daisuke, et al.
Publicado: (2017)

Prediction of nocturnal hypoglycemia unawareness by fasting glucose levels or post-breakfast glucose fluctuations in patients with type 1 diabetes receiving insulin degludec: A pilot study
por: Takahashi, Hiroshi, et al.
Publicado: (2017)

Age at Transition from Pediatric to Adult Care Has No Relationship with Mortality for Childhood-Onset Type 1 Diabetes in Japan: Diabetes Epidemiology Research International (DERI) Mortality Study
por: Onda, Yoshiko, et al.
Publicado: (2016)

Can Fasting Glucose Levels or Post-Breakfast Glucose Fluctuations Predict the Occurrence of Nocturnal Asymptomatic Hypoglycemia in Type 1 Diabetic Patients Receiving Basal-Bolus Insulin Therapy with Long-Acting Insulin?
por: Mitsuishi, Sumie, et al.
Publicado: (2015)

The relationship between HbA1c values and the occurrence of hypoglycemia as assessed by continuous glucose monitoring in patients with type 1 diabetes
por: Tsujino, Daisuke, et al.
Publicado: (2016)

Prospective randomized study for optimal insulin therapy in type 2 diabetic patients with secondary failure
por: Miyashita, Yumi, et al.
Publicado: (2008)

Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): Crossover pilot study (J-VICTORIA study)
por: Sakamoto, Masaya, et al.
Publicado: (2012)

24-Hour Glycemic Variations in Drug-Naïve Patients with Type 2 Diabetes: A Continuous Glucose Monitoring (CGM)-Based Study
por: Ando, Kiyotaka, et al.
Publicado: (2013)

Changes in body mass index, leptin and adiponectin in Japanese children during a three-year follow-up period: a population-based cohort study
por: Nishimura, Rimei, et al.
Publicado: (2009)

Continuous glucose monitoring with Humalog Mix 25 versus Humalog Mix 50, twice daily: A comparative pilot study -Results from the Jikei-EValuation of insulin Lispro mixture on pharmacodynamics and glycemic VariancE (J-EVOLVE) study
por: Nishimura, Rimei, et al.
Publicado: (2010)

Non-Alcoholic Fatty Liver Disease Markers Associated with Fasting Serum Insulin and Urinary Albumin Excretion Independent of Fasting Plasma Glucose
por: Katoh, Shuichi, et al.
Publicado: (2020)

Which is better, high‐dose metformin monotherapy or low‐dose metformin/linagliptin combination therapy, in improving glycemic variability in type 2 diabetes patients with insufficient glycemic control despite low‐dose metformin monotherapy? A randomized, cross‐over, continuous glucose monitoring‐based pilot study
por: Takahashi, Hiroshi, et al.
Publicado: (2018)

Prevalence of albuminuria and renal dysfunction, and related clinical factors in Japanese patients with diabetes: The Japan Diabetes Complication and its Prevention prospective study 5
por: Shikata, Kenichi, et al.
Publicado: (2019)

Effect of Hemodialysis on Plasma Glucose Profile and Plasma Level of Liraglutide in Patients with Type 2 Diabetes Mellitus and End-Stage Renal Disease: A Pilot Study
por: Osonoi, Takeshi, et al.
Publicado: (2014)

Effect of the FreeStyle Libre™ flash glucose monitoring system on glycemic control in individuals with type 2 diabetes treated with basal–bolus insulin therapy: An open label, prospective, multicenter trial in Japan
por: Ogawa, Wataru, et al.
Publicado: (2020)

Inside the Insulin Secretory Granule
por: Germanos, Mark, et al.
Publicado: (2021)

Isolation and Proteomics of the Insulin Secretory Granule
por: Norris, Nicholas, et al.
Publicado: (2021)

Insulin secretory capacity and insulin sensitivity in impaired fasting glucose in Japanese
por: Mitsui, Rie, et al.
Publicado: (2012)

Successful control of a case of severe insulin allergy with liraglutide
por: Kawanami, Daiji, et al.
Publicado: (2013)

Commentary to “Differential Effect of Hypoalbuminemia on Hypoglycemia on Type 2 Diabetes Patients Treated with Insulin Glargine 300 U/ml and Insulin Degludec” by Kawaguchi et al. Diabetes Therapy 2019
por: Pieber, Thomas R., et al.
Publicado: (2020)

Is it possible to predict the onset of nocturnal asymptomatic hypoglycemia in patients with type 1 diabetes receiving insulin degludec? Potential role of previous day and next morning glucose values
por: Takahashi, Hiroshi, et al.
Publicado: (2020)

Effect of Serum Cholesterol on Insulin Secretory Capacity: Shimane CoHRE Study
por: Wada, Masayuki, et al.
Publicado: (2016)

Treatment strategy for type 2 diabetes from the perspective of systemic vascular protection and insulin resistance
por: Utsunomiya, Kazunori
Publicado: (2012)

Insulin Secretory Capacity and Insulin Resistance in Korean Type 2 Diabetes Mellitus Patients
por: Kim, Jong-Dai, et al.
Publicado: (2016)

SOLUBILIZING EFFECT OF NUCLEOTIDES ON ISOLATED INSULIN SECRETORY GRANULES
por: Hellman, B., et al.
Publicado: (1970)

Age-Dependent Labeling and Imaging of Insulin Secretory Granules
por: Ivanova, Anna, et al.
Publicado: (2013)

Secretory Phospholipase A2s in Insulin Resistance and Metabolism
por: Kuefner, Michael S.
Publicado: (2021)

Relationship between hemoglobin A1c and cardiovascular disease in mild-to-moderate hypercholesterolemic Japanese individuals: subanalysis of a large-scale randomized controlled trial
por: Nishimura, Rimei, et al.
Publicado: (2011)

Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease
por: Matoba, Keiichiro, et al.
Publicado: (2019)

Targeting Redox Imbalance as an Approach for Diabetic Kidney Disease
por: Matoba, Keiichiro, et al.
Publicado: (2020)

Insulin Secretory Defect and Insulin Resistance in Isolated Impaired Fasting Glucose and Isolated Impaired Glucose Tolerance
por: Aoyama-Sasabe, Sae, et al.
Publicado: (2016)

Duration of diabetes and types of diabetes therapy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention prospective study 3 (JDCP study 3)
por: Hayashino, Yasuaki, et al.
Publicado: (2016)

The Physiology, Pathology, and Therapeutic Interventions for ROCK Isoforms in Diabetic Kidney Disease
por: Matoba, Keiichiro, et al.
Publicado: (2020)

Endothelial Dysfunction in Diabetes
por: Takeda, Yusuke, et al.
Publicado: (2020)

Conversion of proinsulin to insulin occurs coordinately with acidification of maturing secretory vesicles
Publicado: (1986)

New liver–β‐cell axis that controls insulin secretory capacity
por: Matsuzaka, Takashi, et al.
Publicado: (2014)

Insulin secretory defect may be the major determinant of GDM in lean mothers
por: Fakhrul-Alam, M., et al.
Publicado: (2020)

VAMP4 regulates insulin levels by targeting secretory granules to lysosomes
por: Li, Min, et al.
Publicado: (2022)

Characterization of insulin crystalline form in isolated β-cell secretory granules
por: Asai, Seiya, et al.
Publicado: (2022)

ROCK Inhibition May Stop Diabetic Kidney Disease
por: Matoba, Keiichiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8cts76uvtnepve7h3jhmdiupc8